AARTIPHARM.NS Valuations

Quarterly trend of key valuation metrics

Metric	Current (TTM) TTM Baseline	Q2 '26 30.06.2026	Q1 '26 31.03.2026	Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap	77.58B EUR	61.64B EUR	53.66B EUR	68.21B EUR
Enterprise Value	85.39B EUR	61.64B EUR	61.27B EUR	68.21B EUR
Valuation Multiples
Trailing P/E	36.4x	28.92x	29.32x	55.95x
Forward P/E	33.55x	--	--	--
Price to Sales	3.94x	3.13x	2.95x	5.51x
Price to Book	3.65x	--	2.53x	--
EV/Revenue	4.34x	3.13x	3.37x	5.51x
EV/EBITDA	19.43x	13.65x	15.39x	25.13x
Price to FCF (P/FCF)	--	--	--	--
EV/FCF	--	--	--	--
FCF Yield	--	--	--	--